NCBI National Center for Biotechnology Information |
5NX1: Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy | ||||||||||||||||||
* Click molecule labels to explore molecular sequence information.
|